Journal of Foot and Ankle Surgery (Asia Pacific)

Register      Login

VOLUME 11 , ISSUE 1 ( January-March, 2024 ) > List of Articles

CASE REPORT

Recurrent Synovial Chondromatosis of the Fifth Metatarsophalangeal Joint of the Foot: A Case Report

Vijay Kumar Digge, MLV Sai Krishna, Anmol Anand, Sumit Kumar

Keywords : Foot, Metatarsophalangeal joint, Recurrence, Synovial chondromatosis

Citation Information : Digge VK, Krishna MS, Anand A, Kumar S. Recurrent Synovial Chondromatosis of the Fifth Metatarsophalangeal Joint of the Foot: A Case Report. J Foot Ankle Surg Asia-Pacific 2024; 11 (1):33-37.

DOI: 10.5005/jp-journals-10040-1279

License: CC BY-NC 4.0

Published Online: 30-12-2023

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: Primary synovial chondromatosis is a disease occurring in normal joints and is characterized by the formation of hyaline cartilage in the subintimal layer of the synovium and loose body formation eventually leading to degenerative arthritis. Though it mostly affects large joints, it can rarely involve small joints of the foot as well. The treatment is excision of the loose bodies along with complete synovectomy because partial synovectomy leads to recurrence. The disorder is rarely associated with malignant transformation as well and hence the excised tissue should always be sent for histopathological examination. Case description: A 15-year-old girl presented to us with a painful swelling over the fifth metatarsophalangeal joint of the foot. She had a past history of similar complaints two years ago for which she underwent surgical excision of the same. She presented to us again with recurrence, for which she again underwent surgical excision and the biopsy was sent for histopathological examination which was suggestive of metaplastic calcification with no evidence of malignant transformation. Conclusion: The treatment for synovial chondromatosis is synovectomy and loose body removal either as an arthroscopic or open procedure, and incomplete synovectomy has been attributed to higher recurrence rates. Malignant transformation though rare has also been described and should always be suspected in a recurrent disease that has rapid growth and bone destruction and requires histopathological examination.


HTML PDF Share
  1. McKenzie G, Raby N, Ritchie D. A pictorial review of primary synovial osteochondromatosis. Eur Radiol 2008;18(11):2662–2669. DOI: 10.1007/s00330-008-1024-8
  2. Chiang CH, Jou IM, Wang PH, et al. Synovial osteochondromatosis of the second metatarsophalangeal joint: a case report. J Foot Ankle Surg 2011;50(4):458–461. DOI: 10.1053/j.jfas.2011.03.015
  3. Galat DD, Ackerman DB, Spoon D, et al. Synovial chondromatosis of the foot and ankle. Foot Ankle Int 2008;29(3):312–317. DOI: 10.3113/FAI.2008.0312
  4. Brucher N, Faruch-Bilfeld M, Molinier F, et al. Primary synovial osteochondromatosis of the first interphalangeal joint of the foot: a case report. Diagn Interv Imaging 2014;95(4):451–453. DOI: 10.1016/j.diii.2013.10.003
  5. Kim JB, Song IS, Shin SY, et al. Primary synovial chondromatosis of the talonavicular joint: a case report. Foot Ankle Surg 2016;22(4):e25–e28. DOI: 10.1016/j.fas.2016.08.003
  6. Matsuyama T, Suzuki T, Yoshida Y, et al. Synovial osteochondromatosis of the metatarsophalangeal joint of the great toe. Gan No Rinsho 1986;32(9):1051–1055. PMID: 3747157.
  7. McCarthy C, Anderson WJ, Vlychou M, et al. Primary synovial chondromatosis: a reassessment of malignant potential in 155 cases. Skeletal Radiol 2016;45(6):755–762. DOI: 10.1007/s00256-016-2353-3
  8. Anract P, Katabi M, Forest M, et al. Synovial chondromatosis and chondrosarcoma. A study of the relationship between these two diseases. Rev Chir Orthop Reparatrice Appar Mot 1996;82(3):216–224. PMID: 9005459.
  9. Fetsch JF, Vinh TN, Remotti F, et al. Tenosynovial (extraarticular) chondromatosis: an analysis of 37 cases of an underrecognized clinicopathologic entity with a strong predilection for the hands and feet and a high local recurrence rate. Am J Surg Pathol 2003;27(9):1260–1268. DOI: 10.1097/00000478-200309000-00010
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.